Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
15.10
+0.48 (3.28%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Anika Therapeutics Employees
Anika Therapeutics had 235 employees as of December 31, 2025. The number of employees decreased by 53 or -18.40% compared to the previous year.
Employees
235
Change (1Y)
-53
Growth (1Y)
-18.40%
Revenue / Employee
$494,736
Profits / Employee
-$47,077
Market Cap
200.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,120 |
| Aurora Cannabis | 1,028 |
| Canopy Growth | 960 |
| Organogenesis Holdings | 854 |
| Lifecore Biomedical | 382 |
| Akebia Therapeutics | 194 |
| Alpha Teknova | 158 |
| Journey Medical | 58 |
ANIK News
- 9 days ago - Anika Therapeutics Transcript: AGM 2026 - Transcripts
- 19 days ago - Anika Therapeutics Proxy statement: Proxy filing - Filings
- 22 days ago - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 26 days ago - Anika Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Anika Therapeutics reports Q1 EPS 27c vs.(6c) last year - TheFly
- 2 months ago - Anika Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Anika Therapeutics Earnings release: Q1 2026 - Filings
- 2 months ago - Anika Therapeutics Slides: Q1 2026 - Filings